Menu
  • Find a Doctor
  • International Patients
  • Newsroom
  • Contact Us
  • Patients & Families
  • Education
  • Research
  • Departments & People
  • Transfer a Patient
  • Get a Second Opinion
  • Donate to The Barrow

    Contact Dr. Turner

    Email [email protected]

    Gregory Turner, PhD

    Program Manager, Preclinical Imaging

    Gregory Turner, PhD, is the preclinical imaging program manager in the Keller Center for Imaging Innovation at Barrow Neurological Institute. He oversees the operation of the Barrow-ASU Center for Preclinical Imaging.

    Dr. Turner’s expertise includes biomedical engineering and imaging science. He is a member of the International Society for Magnetic Resonance in Medicine.

    Dr. Turner received a master’s degree in electrical engineering from the University of Alabama and a master’s degree in biomedical engineering from the University of Alabama at Birmingham, where he also earned his doctorate in biomedical engineering. He completed a graduate research fellowship in the Department of Biomedical Engineering at the University of Alabama at Birmingham and a postdoctoral fellowship at the Vanderbilt University Institute of Imaging Science.

    Dr. Turner’s research interests include developing and implementing imaging methods for studying a variety of disease models, including Alzheimer’s disease, inflammation, cancer, and spinal cord injury. He also has an interest and background in functional MRI and cardiac imaging.

    Education & Training
    • Postdoctoral Fellowship, Vanderbilt University, Institute of Imaging Science, 2004-2006
    • PhD, University of Alabama at Birmingham, Biomedical Engineering, 2004
    • Research Fellowship, University of Alabama at Birmingham, 1999-2004
    • MS, University of Alabama at Birmingham, Biomedical Engineering, 2002
    • MS, University of Alabama, Electrical Engineering, 1996
    • BS, University of Alabama, Electrical Engineering, 1993
    Professional Memberships
    • International Society for Magnetic Resonance in Medicine
    Selected Publications
    1. Martirosyan NL, Turner GH, Kaufman J, Patel AA, Belykh E, Kalani MY, Theodore N, Preul MC. Manganese-enhanced MRI offers correlation with severity of spinal cord injury in experimental models. Open Neuroimag J. 2016;10:139-147.
    2. Woolf EC, Curley KL, Liu Q, Turner GH, Charlton JA, Preul MC, Scheck AC. The ketogenic diet alters the hypoxic response and affects expression of proteins associated with angiogenesis, invasive potential and vascular permeability in a mouse glioma model. PLoS One. 2015;10(6):e0130357.
    3. Yin J, Turner GH, Coons SW, Maalouf M, Reiman EM, Shi J. Association of amyloid burden, brain atrophy and memory deficits in aged apolipoprotein epsilon4 mice. Curr Alzheimer Res. 2014;11(3):283-290.
    4. Kaufman JA, Turner GH, Holroyd PA, Rovero F, Grossman A. Brain volume of the newly-discovered species Rhynchocyon udzungwensis (Mammalia: Afrotheria: Macroscelidea): implications for encephalization in sengis. PLoS One. 2013;8(3):e58667.
    5. Bell JC, Liu Q, Gan Y, Liu Q, Liu Y, Shi FD, Turner GH. Visualization of inflammation and demyelination in 2D2 transgenic mice with rodent MRI. J Neuroimmunol. 2013;264(1-2):35-40.
    6. Yin JX, Turner GH, Lin HJ, Coons SW, Shi J. Deficits in spatial learning and memory is associated with hippocampal volume loss in aged apolipoprotein E4 mice. J Alzheimers Dis. 2011;27(1):89-98.
    7. Hao J, Simard AR, Turner GH, Wu J, Whiteaker P, Lukas RJ, Shi FD. Attenuation of CNS inflammatory responses by nicotine involves alpha7 and non-alpha7 nicotinic receptors. Exp Neurol. 2011;227(1):110-119.
    8. Zhang N, Wang F, Turner GH, Gore JC, Avison MJ, Chen LM. Intra- and inter-subject variability of high field fMRI digit maps in somatosensory area 3b of new world monkeys. Neuroscience. 2010;165(1):252-264.
    9. Olzinski AR, Turner GH, Bernard RE, Karr H, Cornejo CA, Aravindhan K, Hoang B, Ringenberg MA, Qin P, Goodman KB, Willette RN, Macphee CH, Jucker BM, Sehon CA, Gough PJ. Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment. Arterioscler Thromb Vasc Biol. 2010;30(2):253-259.
    10. Turner GH, Olzinski AR, Bernard RE, Aravindhan K, Boyle RJ, Newman MJ, Gardner SD, Willette RN, Gough PJ, Jucker BM. Assessment of macrophage infiltration in a murine model of abdominal aortic aneurysm. J Magn Reson Imaging. 2009;30(2):455-460.

    About Barrow

    Since our doors opened as a regional specialty center in 1962, we have grown into one of the premier destinations in the world for neurology and neurosurgery. Our experienced, highly skilled, and comprehensive team of neurological specialists can provide you with a complete spectrum of care–from diagnosis through outpatient neurorehabilitation–under one roof. Barrow Neurological Institute: Discover. Educate. Heal.